Launch Date
09/09/2019
Credit Amount
0.00 Expired
Credit Expires
12/31/2021
The opioid abuse epidemic has resulted in an alarming increase in opioid-related overdoses and deaths; however, the severe and lethal consequences of opioid misuse is preventable with the use of medication-assisted treatment (MAT), which is a proven, effective tool for patients with opioid use disorder (OUD).
Research has demonstrated that MAT is effective in reducing opioid use and overdoses, increasing treatment retention, diminishing risky behaviors that contribute to the transmission of HIV and hepatitis C virus, and reducing morbidity and mortality. Unfortunately, access to treatment is a major issue, with a number of factors – including stigma toward MAT and those receiving it, regulations and a lack of quality standards for treatment programs, an inadequate and unevenly distributed workforce, lack of confidence/knowledge and institutional support, and the belief that patients should be able to abstain without MAT – contributing to access.
This CME Outfitters Snack features expert faculty expanding on best practices for MAT initiation particularly in diverse care settings such as the VA system, criminal justice settings, hospitals, and outpatient clinics, by examining the neurobiology of opioid addiction and the efficacy of opioid agonists and antagonists in reducing illicit opioid use.
At the end of this CME/CE activity, participants should be able to:
The following learning objectives pertain only to those requesting CNE or CPE credit:
Supported by an educational grant from Indivior Inc.
Addiction specialists, physicians, nurse practitioners, physician assistants, pharmacists, treatment counselors, medical students, and other members of the addiction care team.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Fuehrlein reports that he is a consultant for the American Academy of Addiction Psychiatry.
Dr. Wasser has no disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.
NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-19-046-H01-P.
Call us at 877.CME.PROS (877.263.7767).
SN-116-090919-59